Singapore: Japan-based Daiichi Sankyo has decided to expand its collaborative drug discovery program with universities a...
Singapore: Eli Lilly and Boehringer Ingelheim are making a slight adjustment to their diabetes alliance with respect to...
Singapore: Australia's Cellmid has completed its first in-life diabetic nephropathy study with anti-midkine antibodies (...
Singapore: Positive results were reported from Takeda Pharmaceutical's international, randomized, placebo-controlled, ...
Singapore: Global organization, International Osteoporosis Foundation (IOF), and New Zealand dairy firm, Fonterra have c...
Singapore: Vanda Pharmaceuticals has withdrawn its application from European Medicines Agency for a centralized marketin...
Singapore: Research based pharmaceutical company, AbbVie, has made investment of around USD320 million in Singapore to s...
Singapore: Prana Biotechnology reported on the progress of its lead development asset PBT2, which is in phase II trials ...
Singapore: Medivation and Astellas Pharma have established an updated interim analysis plan for the Prevail trial, a glo...
Singapore: Global pharmaceutical firm, Novartis, has acquired CoStim Pharmaceuticals, a privately held biotechnology com...
Singapore: Cytos Biotechnology revealed additional results of the phase IIa clinical trial with CYT003, a first-in-class...
Singapore: Prism Pharma, a drug discovery company focused on developing small molecule technologies that modulate protei...
Singapore: Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company revealed results from a post-hoc analysis, whi...
Singapore: Vital Smith, a Korean startup which focuses on developing innovative technology for diagnostics devices is r...
Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) ...
Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Ch...
Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Healt...
Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for...
